Format

Send to

Choose Destination
See comment in PubMed Commons below
Can J Cardiol. 2007 Aug;23(10):779-81.

The role of enhanced external counterpulsation in the treatment of angina and heart failure.

Author information

  • 1Department of Medicine, Chicago Medical School, Chicago, IL 60064, USA. rohit.arora@med.va.gov

Abstract

As the incidence of angina and heart failure continue to rise, new therapeutic options will be needed to treat patients who remain symptomatic or who are intolerant to current treatment. Enhanced external counterpulsation (EECP) is a noninvasive modality being investigated in both angina and congestive heart failure patients. It has been proven to provide symptomatic benefit in angina patients, but has not been proven to show an increase in life expectancy or decrease in cardiovascular events. EECP in heart failure has been proven to be safe, but its efficacy is still uncertain. The present paper summarizes the current literature on the clinical use of EECP in angina and heart failure.

PMID:
17703254
PMCID:
PMC2651381
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center